NCT03150212

Effect of Saccharomyces Cerevisiae on the Improvement of Gastro-intestinal Disorders Associated to IBS With C Phenotype

Randomized Double Blind Placebo-controlled Clinical Study : Effect of IBSIUM on the Improvement of Gastro-intestinal Disorders Associated to the Irritable Bowel Syndrome (IBS) With C Phenotype (Predominant-constipation)

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 456 (actual)
• Sponsor: Lesaffre International · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Accepted

Summary

The main objective is to assess the effect of an 8-week daily supplementation with IbSium® (probiotic yeast Saccharomyces cerevisiae CNCM I-3856) on the improvement gastro-intestinal disorders associated to the type C IBS (constipation predominant).

Conditions

• Constipation-predominant Irritable Bowel Syndrome

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Saccharomyces cerevisiae CNCM I-3856	2 capsules daily, just before the breakfast with a glass of water, during 8 weeks.
DIETARY_SUPPLEMENT	Placebo	2 capsules daily, just before the breakfast with a glass of water, during 8 weeks.

Timeline

• Start date: 2017-03-20
• Primary completion: 2019-05-09
• Completion: 2019-05-09
• First posted: 2017-05-12
• Last updated: 2019-05-21

Locations

5 sites across 1 country: France